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Background:  Ultrasound targeted microbubble destruction (UTMD) has become an organ specific gene and a novel tool for drug delivery. The aim 
of this study was to evaluate the therapeutic effects of rAAV2-SERCA2a gene targeted transfection to myocardium by UTMD in rats with myocardial 
infarction (MI).
Methods:  Rats were divided into Sham operation group, MI group and gene therapy group. The left anterior descending coronaries of 35 rats 
were ligated to induce acute MI. Ten rats in sham operation group were only subjected to open chest procedure. One week after inducing MI, rats 
with left ventricular ejection fraction more than 80% were excluded by echocardiography, and the survivors MI rats were randomly divided into 2 
groups, MI group and gene therapy group. Microbubbles contrast agent mixed with rAAV2-SERCA2a were infused into the caudal vein of rats in gene 
therapy group, and following UTMD. Microbubbles contrast agent was infused into the caudal vein of rats in Sham operation group and MI group, 
and following UTMD. Rats were then sacrificed and tissues were sliced at 4 weeks after UTMD. Echocardiography was performed to evaluate the 
change in left ventricular function. RT-PCR and Western blotting were used to detect the mRNA and protein expression of SERCA2a gene in 3 groups. 
The proinflammatory cytokines (TNF-_, IL-6) and vasoactive peptides (Ang II, ET-1 and ANP) were analyzed. Liver and kidney function tests were also 
assessed by determining the serum parameters.
Results:  Compared with MI group, expression of SERCA2a in myocardial tissues was obviously improved in gene therapy group (P<0.05), while no 
difference was found in sham operation group. Expression of SERCA2a was low in other tissues, and no difference was found between before and 
after gene transduction. Compared with MI group, expression of each neuroendocrine factor recovered at various levels after SERCA2a transduction. 
There was no difference in live and kidney functional parameters among 3 groups.
Conclusions:  UTMD could deliver rAAV2-SERCA2a gene transfection into the infracted myocardium, which could provide a novel strategy for gene 
therapy of MI.
